Posts tagged “Biotech & Life Science”
The experimental shot is the most advanced candidate vaccine for malaria but results from previous trials have been disappointing. Research published in 2012 showed the shot only reduced malaria cases by about 30 percent in babies aged six to 12 weeks, the target age for immunization.
Despite cuts in its own state funding, the North Carolina Biotechnology Center is doubling the size of loans it makes to early-stage life science companies. Why? Lack of private-sector capital, says Peter Ginsberg, the Center's vice president for business and technology development. WRAL TechWire Insiders can read the details in this exclusive interview.
Drug giant GlaxoSmithKline, hurt in part by a 20 percent decline in sales in China where the company is under criminal investigation, reports revenues and earnings that missed analysts' expectations on Wednesday. GSK also reduced its growth forecast for 2014 from as much as 8 percent to "basically similar" to 2013 and says it can't estimate what the financial impact could be from the China case.
Even with sales and profits declining sharply from a year ago, a cut in a growth forecast for this year and continuing legal issues resulting from a criminal investigation in China, GSK's chief executive officer Andrew Witty puts a positive spin on the state of the company in a video interview.
StubHub hacked; Viamet's new exec; LinkedIn's $175M buy; Cisco boosts Euro startups; 4K TVs boost LG
In today's Bulldog wrapup of tech and life science news: StubHub is hacked; Viamet names chief development officer; LinkedIn makes an acquisition; Cisco takes entrepreneur program to Europe; and 4K TVs for World Cup boost LG.
Sprout Pharmaceuticals has positioned its drug as the first female equivalent to Viagra. And the privately held firm has turned to scores of investors for financial help in driving the drug toward FDA approval.
Farming continues to evolve, becoming even more high tech. The latest wave is called "precision agriculture," and it was the topic of the NC Ag Biotech Professional Forum at the NC Biotechnology Center, uses GPS guided, self-steering equipment, drones to monitor crops, precise, hyper-local weather reports, and the collection and analysis of data in real time for immediate action or strategic planning. WRAL TechWire Insider Allan Maurer has the exclusive details.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with nearly 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.
Startup says aloha to name after Hawaii protests; FDA-Pozen update; new Tantalus exec; Apple $400M ebook settlement; Novartis earnings; Visa's new system
In today's Bulldog wrapup of life science and technology news: A L.A. company changes its name after protests in Hawaii; FDA accepts Pozen application; smart grid firm Tantalus in Raleigh names COO; Apple faces $400M ebook settlement; Novartis earnings; and Visa launches new online payment system.
TyraTech is rolling out its head lice product in the U.K. and is funding its European expansion with $6 million in new funding. The company, which moved to Morrisville in 2011, says the head lice market is a $150 million a year opportunity.
Chimerix, the Durham-based drug company working on experimental medicine that could save the life of a seven-year-old Josh Hardy, was granted approval by the U.S. Food and Drug Administration to administer the drug to the boy in March. On Wednesday, his mother said he is doing well and going home.
Raleigh biotechnology company Agile Sciences has landed a $1.5 million National Institutes of Health grant to help develop its cystic fibrosis therapy derived from sea sponges.
Yahoo earnings fall; N.C. Solar Center's new name; Novartis-Google 'Glass' contacts; Cree expands; Sling's new devices
In today's Bulldog wrapup of technology and life science news: Yahoo takes a hit; N.C. Solar Center gets a new name; Novartis teams with Google for "Glass" contacts; Cree adds space; Sling's new devices.
GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially.